George Van Buren

5PUBLICATIONS

40CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Sep 27, 2026

Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences for Survival.

|Jan 02, 2026

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo

|Feb 25, 2023

MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients.

Young-Il Kim, Robert Luke Pecha, Tara Keihanian

|Jan 31, 2023

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.

Erika Y Faraoni, Kanchan Singh, Vidhi Chandra

|Mar 29, 2019

Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.

Ethan Poteet, Dongliang Liu, Zhengdong Liang

Pageof 1

Frequent Collaborators

Qizhi Yao

Erika Y Faraoni

Kanchan Singh

Vidhi Chandra

Olivereen Le Roux

Yulin Dai

Ismet Sahin

Baylee J O'Brien

Lincoln N Strickland

Le Li

Frequent Collaborators

Qizhi Yao

Erika Y Faraoni

Kanchan Singh

Vidhi Chandra